https://www.selleckchem.com/pr....oducts/yap-tead-inhi
However, we identified only 6 relevant published articles. We used these as the basis for a proposed framework that is predicated on the thoughtful disclosure of adverse events and has 3 main levels (i.e., patient, clinician, and institutional level). For each level, we identify barriers to patient participation and potential strategies to overcome them. CONCLUSIONS The proposed framework can be used as a starting point to promote patient involvement in error investigations. Involving patients in patient safety i
Aimer
Commentaire
Partagez
